Virtual Reality Decreases Child Anxiety and Pain as Well as Caregiver Anxiety and Pain Perception During Orthopaedic Clinic Office Procedures

Sponsor
University of Michigan (Other)
Overall Status
Recruiting
CT.gov ID
NCT05708586
Collaborator
(none)
100
1
2
35.8
2.8

Study Details

Study Description

Brief Summary

The purpose of this study is to demonstrate that the use of a virtual reality experience can decrease child and caregiver anxiety and pain for simple orthopaedic office procedures.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Control
  • Device: Virtual Reality (VR)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Virtual Reality Decreases Child Anxiety and Pain as Well as Caregiver Anxiety and Pain Perception During Orthopaedic Clinic Office Procedures
Actual Study Start Date :
Dec 8, 2021
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control

Standard comfort given

Behavioral: Control
This is the control condition and anxiety is addressed in a standard way of having the care taker calm the child during the intervention.

Experimental: Virtual Reality (VR)

Device: Virtual Reality (VR)
The child who is undergoing a procedure uses VR as a distraction during the intervention

Outcome Measures

Primary Outcome Measures

  1. Child pain score [Up to 24 hours following procedure]

    Assessed by Wrong-Baker Children's Faces Pain Scale: The scale shows a series of faces ranging from a happy face at 0 which represents "no hurt" to a crying face at 10 which represents "hurts worst." Based on the faces and descriptions, the patient chooses the face that best describes their level of pain.

  2. Child anxiety (7 years old and older) [Up to 24 hours following procedure]

    Assessed by State-Trait Anxiety Inventory for Children (STAIC): 20 questions with 3 answer options for each question. Scores range from 20 to 60 for state and 20 to 60 for trait with 60 being the higher (more or worse) anxiety on self-assessment.

  3. Child anxiety (Younger than 7 years old) [Up to 24 hours following procedure]

    Assessed by Children's Fear Scale: The Children's Fear Scale (CFS) is used to measure the anxiety or fear level of the children. The one-item scale consists of a row of five sex neutral faces ranging from a no fear (neutral) face on the far left to a face showing extreme fear on the far right.

Secondary Outcome Measures

  1. Parental anxiety [Up to 24 hours following procedure]

    Assessed by State-Trait Anxiety Inventory (STAI): a 20 question inventory where each question is on a Likert scale 1-4. The total range of the inventory is 20-80 with higher scores indicating more anxiety (please note that some questions are reverse coded).

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Undergoing cast removal, pin removal, or suture removal in study affiliated clinic
Exclusion Criteria:
  • History of seizures

  • Pregnant, have preexisting binocular vision abnormalities or psychiatric disorders, or suffer from a heart condition or other serious medical condition

  • Patients can't have implanted medical devices including cardiac pacemakers, hearing aids and defibrillators

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Study Chair: Noelle Whyte, MD, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Noelle Whyte, Clinical Assistant Professor, University of Michigan
ClinicalTrials.gov Identifier:
NCT05708586
Other Study ID Numbers:
  • HUM00197192
First Posted:
Feb 1, 2023
Last Update Posted:
Feb 1, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Noelle Whyte, Clinical Assistant Professor, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 1, 2023